
The summary:
1. Medical Affairs is underutilised
2. Medical Affairs occupies a unique position in the business that would allow it to rise to a position of prominence
3. To make this shift Medical Affairs needs to step up in capability, strategic thinking and leadership
So far, so good (predictable).
But here's where it gets interesting - the drive to see this happening, which has been spoken about since 1998 is now going to materialise in the space of the next 5 years.
This is one that got them talking.
Read the full report here
___
This is part of a series of posts by LUCENT biopharma – focused on the future of medicines and their marketing in the biopharma sector.
For more information, please go to www.lucentbiopharma.com